ALRISE's proprietary ImSus® technology is an innovative, economic and high quality platform technology for the manufacture of drug-loaded polymeric microparticles.

ImSus® technology allows an efficient encapsulation of both hydrophilic and hydrophobic drugs independent of the molecule size (from small molecules to peptides) and is a powerful tool for the engineering of controlled-release formulations.

ImSus® technology is compatible with all polymers commonly used for drug delivery applications of long-acting injectables. According to the specific target product profile, formulations are designed for controlled release durations ranging from a few days up to 6 months.

ImSus® technology produces homogeneous microparticle morphologies (capsules, sponges or spheres) resulting in highly reproducible drug release performances. All excipients used are either approved by FDA for parenteral applications or generally regarded as safe (GRAS).

ALRISE Biosystems GmbH
Robert-Roessle-Straße 10
13125 Berlin, Germany
Phone +49 30.94 89 24 83
Fax +49 30.94 89 24 82